COVID-19 continues to disproportionately affect patients with cancer because of their underlying immunocompromised state. Strategies to mitigate the impact of COVID-19 on patients with cancer include vaccination, which has demonstrated some level of protection, at least against serious complications such as respiratory failure and death, with limited safety concerns. In this narrative review, we discuss the current COVID-19 vaccines that are available in the United States, the published data regarding vaccine efficacy and safety in patients with cancer, current vaccination guidelines, and future directions.
Keyphrases
- coronavirus disease
- sars cov
- respiratory failure
- respiratory syndrome coronavirus
- extracorporeal membrane oxygenation
- randomized controlled trial
- mechanical ventilation
- risk factors
- mesenchymal stem cells
- bone marrow
- machine learning
- current status
- cell therapy
- acute respiratory distress syndrome
- clinical practice
- smoking cessation